ImmuPharma plc (LON:IMM – Get Free Report) shares rose 18.6% during mid-day trading on Thursday . The stock traded as high as GBX 4.50 ($0.06) and last traded at GBX 3.98 ($0.05). Approximately 6,527,307 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 13,541,125 shares. The stock had previously closed at GBX 3.36 ($0.04).
ImmuPharma Stock Down 7.7 %
The stock has a 50-day moving average price of GBX 3.80 and a 200 day moving average price of GBX 2.32. The firm has a market capitalization of £13.34 million, a price-to-earnings ratio of -5.42 and a beta of 1.53.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What Makes a Stock a Good Dividend Stock?
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Investing in Travel Stocks Benefits
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
